SCHEMBL14924969

SCHEMBL14924969

Cc1cc(OCc2ccccc2)c(C(=S)Nc2ccc(N3CCOCC3)cc2)cc1C(C)C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP3A4 P08684 1/20 0.46
LRRK2 Q5S007 1/20 0.46
SLCO1B1 Q9Y6L6 1/20 0.46
MAPK14 Q16539 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 11/20 0.44
ALDH1A1 P00352 4/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
HCRTR1 O43613 1/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ALOX15 P16050 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5002701 0.93 KMT2A (0.48) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL14924967 0.89 LRRK2 (0.59) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL14924965 0.88 MEN1 (0.45) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL5002610 0.82 LRRK2 (0.60) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL30779696 0.82 LRRK2 (0.60) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL5006248 0.80 KMT2A (0.46) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL5006252 0.80 KMT2A (0.46) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL14029812 0.80 KMT2A (0.46) MEN1KMT2ACYP3A4LRRK2SLCO1B1
SCHEMBL14048066 0.79 MAPT (0.53) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL16491121 0.77 MAPT (0.47) MEN1KMT2ACYP3A4LRRK2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116253-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116251-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116252-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116431-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116252-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 MEN1 4815/4885KMT2A 3665/4885CYP3A4 2042/4885
US-20130116253-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 MEN1 4815/4885KMT2A 3665/4885CYP3A4 2042/4885
US-20130116251-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 MEN1 4815/4885KMT2A 3665/4885CYP3A4 2042/4885
US-20130116431-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 MEN1 4815/4885KMT2A 3665/4885CYP3A4 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.